Mark H. O’Hara

Targeting protein–ligand neosurfaces with a generalizable deep learning tool

Transferrin receptor targeting chimeras for membrane protein degradation

Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial

Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps